CT-2106 for the Second Line Treatment of Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00291837
Recruitment Status : Completed
First Posted : February 15, 2006
Last Update Posted : February 26, 2010
Information provided by:
CTI BioPharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : December 2007